A review of the diagnosis and management of neuroleptic-induced parkinsonism to improve patient compliance and therapeutic outcomes.
May aid monitoring for neuroleptic-induced parkinsonism to support adherence; leaves open optimal strategies pending controlled trials.
Basal ganglia side-effects caused by neuroleptic drugs are frequently ignored, misdiagnosed, or mistreated by the patient or physician. Such side-effects must be anticipated and appropriate management instituted so that patient compliance with the drug regimen is increased and the therapeutic relationship is maintained. Side-effects can be detected in frequent and complete examinations of the head and neck, limbs, and chest and back. The various medications for drug-induced parkinsonism are reviewed, with an emphasis on the indications for selection and the effects of each drug. Common errors in the diagnosis and management of side-effects of neuroleptic drugs are summarized.
No takes yet. Share an insight, caveat, or question.
Brian F. Hoffman (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: